Alfred D. Kingsley

2017 - Serina Therapeutics

In 2017, Alfred D. Kingsley earned a total compensation of $547.3K as Former Executive Chairman at Serina Therapeutics.

Compensation breakdown

Option Awards$433,017
Salary$110,769
Other$3,529
Total$547,315

Kingsley received $433K in option awards, accounting for 79% of the total pay in 2017.

Kingsley also received $110.8K in salary and $3.5K in other compensation.

Rankings

In 2017, Alfred D. Kingsley's compensation ranked 11,518th out of 14,666 executives tracked by ExecPay. In other words, Kingsley earned more than 21.5% of executives.

ClassificationRankingPercentile
All
11,518
out of 14,666
22nd
Division
Manufacturing
4,516
out of 5,772
22nd
Major group
Chemicals And Allied Products
1,649
out of 2,075
21st
Industry group
Drugs
1,364
out of 1,731
21st
Industry
Pharmaceutical Preparations
1,064
out of 1,333
20th
Source: SEC filing on November 29, 2019.

Kingsley's colleagues

We found two more compensation records of executives who worked with Alfred D. Kingsley at Serina Therapeutics in 2017.

2017

Michael West

Serina Therapeutics

Chief Executive Officer

2017

Hal Sternberg

Serina Therapeutics

Vice President, Research

News

In-depth

You may also like